1007 GILBERT'S SYNDROME AND HYPERBILIRUBINEMIA IN PROTEASE INHIBITOR THERAPY – AN EXTENDED HAPLOTYPE OF GENETIC VARIANTS INCREASES RISK IN INDINAVIR TREATMENT

✍ Scribed by Lankisch, T.; Behrens, G.; Ehmer, U.; Möbius, U.; Rockstroh, J.; Wehmeier, M.; Kalthoff, S.; Freiberg, N.; Manns, M.; Schmidt, R.; Strassburg, C.

• Book ID: 122893839
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 51 KB
• Volume: 50
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(09)61009-6